EWA
CTSO icon

EP Wealth Advisors’s Cytosorbents Corp CTSO Stock Holding History

EP Wealth Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
28,000
– – ﹤0.01% 1710
2026
Q1 		$15.9K Hold
28,000
– – ﹤0.01% 1490
2025
Q4 		$17.9K Buy
+28,000
New +$21.5K ﹤0.01% 1474
2025
Q2 		$35.8K Hold
28,000
– – ﹤0.01% 1411
2025
Q1 		$28K Hold
28,000
– – ﹤0.01% 1274
2024
Q4 		$25.5K Hold
28,000
– – ﹤0.01% 1230
2024
Q3 		$42K Hold
28,000
– – ﹤0.01% 1169
2024
Q2 		$19.7K Buy
+28,000
New +$24.3K ﹤0.01% 847

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

EP Wealth Advisors's CTSO Position: Q2 2026 in Review

EP Wealth Advisors held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 28,000 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1710.

EP Wealth Advisors first reported a position in CTSO in Q2 2024 and has held it in 8 quarters since. The position peaked at $42K in Q3 2024. 42 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • EP Wealth Advisors held 28,000 shares of Cytosorbents Corp worth $10.5K as of Q2 2026.
  • EP Wealth Advisors left its Cytosorbents Corp share count unchanged in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1710 holding.
  • EP Wealth Advisors first reported a position in Cytosorbents Corp in Q2 2024 and has held it in 8 quarters since.
  • EP Wealth Advisors's Cytosorbents Corp position peaked at $42K in Q3 2024.
  • 42 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.